Join a Paid Rhinovirus Study for Adults Living With COPD
Living with COPD can mean flare ups when you catch a cold. Adults may qualify for a clinical research study at AMR Clinical evaluating an investigational oral medication when a rhinovirus (common cold virus) infection is confirmed. Participation is voluntary and all study-related care and investigational medication or placebo are provided at no cost to those who qualify.
Qualified Participants:
Are adults 40-85
Have been diagnosed with COPD
Have had at least 1 COPD flare-up in the past year
Meet additional eligibility criteria
Qualified Participants May Receive:
Study related care at no cost
Compensation up to $1,625 for study-related time and travel